西门子卫生师和初级卫生保健输入体外诊断合同

经过Labmedica Internationalstaff writers
2018年11月12日

SIEMENS HEALLINENERS（德国Erlangen）已与澳大利亚综合医疗保健提供者初级保健建立了战略合作伙伴关系，以部署70多个Atellica Solution Solution Solution Solution Solution and Clinical Chemistrical Chemistry Analyzers，这标志着该国有史以来最大的合同，用于该国的体外诊断测试。

分析仪与Atellica Diagnostics IT解决方案集成在一起，并将连接到公司的战略合作伙伴Inpeco的FlexLab轨道，以实现全面的实验室自动化，以提供高通量的多学科解决方案，并具有改变澳大利亚临床实验室景观的能力。

西门子卫生师在其诊断和治疗成像以及实验室诊断和分子医学的核心领域提供广泛的产品和服务。初级卫生保健在澳大利亚的所有大陆州都有庞大的业务，该国每三个病理样本中有一个在初级实验室进行测试。西门子卫生技术技术将在新南威尔士州，昆士兰州，维多利亚州和西澳大利亚州推出。

The strategic engagement couples Primary’s expansive network of more than 2,300 national pathology collection sites with workflow improvement and expanded clinical capabilities from Siemens Healthineers to establish a new level of automated diagnostic delivery. Through deep analytics, and intelligent data and process management, Atellica Diagnostics IT software will provide Primary with improved visibility, flexibility and control over its entire operation. Siemens Healthineers and Inpeco SA will deliver this fully automated multidisciplinary solution that will vastly simplify clinical and operational workflows and help Primary achieve better outcomes at much lower costs.

“With the introduction of the Atellica Solution and the complementary, innovative offering of Atellica Diagnostics IT, we’ll turn what has been more than a decade of collaboration with Primary Health Care into an entirely new frontier for the Australian pathology industry,” said Sebastian D’Angelo, General Manager, Laboratory Diagnostics, Australia, Siemens Healthineers.

“This new collaboration will allow us to take Primary’s operational efficiencies to new heights,” said Wes Lawrence, Chief Executive of Pathology at Primary Health Care. “Thanks to this next-generation technology, we’re able to increase productivity, and focus more on value-adding lab activities and less on sample and instrument handling. In doing so, processes will be reduced and testing quality will be advanced, ultimately helping us increase cost savings and focus on the human impact of our work.”



E-mail Print